Strategic Investment Advisors / MI

Position in EXEL — Exelixis, Inc.

CIK 1760540 FARMINGTON HILLS, MI

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,342,241

+$329,800 QoQ

Shares Held

43,048

-8.3% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#251

of 751 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Strategic Investment Advisors / MI holds $2,978,396 across 4 Biotechnology names. EXEL ranks #1 (78.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	43,048	$2,342,241
2	VRTX	Vertex Pharmaceuticals Inc / Ma	746	$370,560
3	GMAB	Genmab A/S	5,653	$155,287
4	DFTX	Definium Therapeutics, Inc.	2,345	$110,308

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,342,241	43,048	-8.3%	Shares	Sole	2026-08-14
2026-03-31	$2,012,441	46,921	+48.4%	Shares	Sole	2026-05-18
2025-12-31	$1,385,378	31,608	-5.2%	Shares	Sole	2026-02-17
2025-09-30	$1,377,065	33,343	+486.6%	Shares	Sole	2025-12-17
2025-06-30	$250,550	5,684	-6.8%	Shares	Sole	2025-08-15
2025-03-31	$225,064	6,096	—	Shares	Sole	2025-04-23
No filing history on record for this holder in this stock.